Pharmafile Logo
Pharmafocus logo
Advanced Search
subcutaneous-injection-tn

First ex vivo human skin platform investigating ISR launched

July 7, 2021
Research and Development

Genoskin has announced the launch of ISR Platform, a novel pre-clinical toolbox designed to study injection site reactions (ISR) in …

News

Summer COVID cases set to reach 2 million with 10 million isolating

July 7, 2021
Research and Development COVID-19, Lockdown, UK, Vaccine, government

Analysis from the Guardian has found that over two million people could contract COVID-19 this summer, which could therefore lead …

News
johnson_and_johnson_jj

EU orders nearly 40 million more J&J COVID vaccines

July 7, 2021
Research and Development

The EU has ordered nearly 40 million more doses of the J&J COVID-19 vaccines for European countries. This is despite …

News
boehringer_biberach_germany_copy

Breakthrough heart failure drug meets primary endpoint

July 7, 2021
Research and Development

The Phase III trial for empagliflozin, a treatment for patients with heart failure with preserved ejection fraction, has met its …

News
pfizer_building_logo2_1

Pfizer’s COVID-19 vaccine efficacy falls to 64% in Israel

July 6, 2021
Manufacturing and Production

Israel has reported a decrease to 64% in the effectiveness of the Pfizer-BioNTech COVID-19 vaccine in preventing infections and symptomatic …

News

UVC light found to inactivate COVID virus in study

July 6, 2021
Manufacturing and Production COVID-19, clinical trials, computer simulations, skin

A new study has found that Ultraviolet C (UVC) emitting lamps are fast, effective, and safe at inactivating SARS-CoV-2, the …

News
sos002

Sosei and InveniAI to collaborate on AI-powered drug discovery

July 6, 2021
Manufacturing and Production

Sosei Heptares and InveniAI have entered a multi-target AI-powered and GPCR-focused drug discovery collaboration. The two companies will combine InveniAI’s …

News

Novel cancer therapy kick starts clinical trials

July 6, 2021
Manufacturing and Production oncology

The first patient has been dosed in Phase 1/2 trials investigating a new form of cancer therapy, gamma delta TCR …

News
roche__tree

MIMETAS and Roche to collaborate on drug development

July 6, 2021
Manufacturing and Production

MIMETAS and Roche have entered into a collaboration to develop human disease models to characterise novel compounds in inflammatory bowel …

News
mufid-majnun-oi20ehignd4-unsplash

Over 600,000 positive COVID tests genomically sequenced in UK

July 5, 2021
Sales and Marketing COVID-19, Delta variant, UK, government, variant

The UK has genomically sequenced more than 600,000 positive COVID-19 test, it was announced on Friday. Genomic sequencing plays a …

News
christina-victoria-craft-whsnkiwwpec-unsplash

Strawberry-flavoured tablet distributed to children with HIV

July 5, 2021
Sales and Marketing

A strawberry-flavoured generic HIV drug has been distributed in Africa for children and babies living with HIV. The drug, which …

News

Visitors with non-EU approved jabs allowed in Madeira

July 5, 2021
Sales and Marketing COVID-19, EU, Vaccine, travel

Popular holiday destination, the Portuguese islands of Madeira, have announced that they will allow visitors with any COVID-19 vaccine, even …

News

BioMed X and Merck launch new Oncology research programme

July 5, 2021
Sales and Marketing

BioMed X and Merck have launched a new joint research programme in oncology. The new program will explore the role …

News

South Korea in talks to produce one billion mRNA vaccine doses

July 5, 2021
Sales and Marketing

South Korea is in talks with mRNA vaccine makers, including Pfizer-BioNtech and Moderna, to produce up to one billion COVID-19 …

News
az

AstraZeneca MPO inhibitor shows promise for heart failure patients

July 2, 2021
Medical Communications

Results released from AstraZeneca’s Phase IIa SATELLITE trial demonstrated that AZD4831, a myeloperoxidase (MPO) inhibitor, achieved pre-specified target engagement in …

News
img_4190-e1376666350337

Congenital adrenal hyperplasia treatment granted MHRA authorisation

July 2, 2021
Medical Communications

The MHRA has granted marketing authorisation to Diurnal’s treatment, Efmody, as treatment of adult and adolescent patients with the rare …

News

J&J COVID vaccine effective against Delta variant

July 2, 2021
Medical Communications

Johnson & Johnson (J&J) has reported that its single-dose Covid-19 vaccine stimulated robust, continued neutralising antibody activity against the Delta …

News

Travellers with Indian-made AZ jab may face European ban

July 2, 2021
Medical Communications COVID-19, India, Vaccine

Up to 5 million Britons planning to travel to Europe may face a travel ban if they have been vaccinated …

News
sachet

Origin Group launches fully recyclable sachet for health sector

July 2, 2021
Medical Communications

The Origin Group has launched a 100% recyclable single-dose sachet which is fully brandable for the health sector. The new …

News
cdc-un8tv9pw2ik-unsplash_1

CureVac vaccine shows only 48% efficacy

July 1, 2021

CureVac’s COVID-19 vaccine has shown only 48% efficacy in its final analysis. This result is only marginally better than the …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026